ArticleShoulder & elbow2025
Short to mid-term functional outcomes of stemless anatomical total shoulder arthroplasty in patients over 70 years of age.
Article in Shoulder & elbow, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anatomical total shoulder arthroplasty (ATSA) is the gold standard for treating primary glenohumeral osteoarthritis (GHOA) in patients with an intact rotator cuff. Recently, reverse total shoulder arthroplasty (RTSA) is increasingly used in patients over 70. Stemless ATSA designs aim to reduce stem-related complications and simplify revisions. This study evaluates functional outcomes and complication rates of stemless ATSA in patients aged 70+ with an intact rotator cuff and at least two years of follow-up. Methods: Forty-three patients met the inclusion criteria. Outcomes were assessed using the Oxford shoulder score (OSS), subjective shoulder value (SSV), and numeric rating scale (NRS) for pain at rest and during activity. Postoperative complications were documented. Results: Thirty-three patients completed follow-up (mean 49.2 months). OSS improved by a mean of 21.7 points (median 48, IQR 42.5-48). SSV increased by 49.5%, NRS pain decreased by 5.7 (rest) and 6.8 (activity), all statistically significant (P < 0.001). Complications included one revision for rotator cuff failure (3%) and one asymptomatic biceps tenodesis failure. No outcome differences were found between age groups 70-79 and 80+. Conclusion: Stemless ATSA in patients aged 70+ with an intact rotator cuff yields significant functional improvement and low complication rates at short- to mid-term follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.